Richard Lathe rlathe@ed.ac.uk
Sir - I write to report adverse effects of venlafaxine from observations on
one subject and from a wider survey of the literature. One subject receiving
venlafaxine (Efexor XL, 75 mg/day) for 6 months reported headaches and related
symptoms of severity sufficient to preclude normal function. Discontinuation
was found impossible, medication was recommenced according to a schedule for
tapered removal.
Following complete discontinuation the headaches disappeared, but investigation
revealed that the subject had experienced debilitating inertia for the period
of the medication. Longer-term problems have also became apparent: 1 month later
the subject still reports sudden episodes of nausea, temporary disconnection,
palpitations, tremor, sweating, unsteadiness.
On investigation I find that this is not unusual. There is a volume of literature
on the acute and chronic adverse effects of discontinuing Venlafaxine, including
nausea, memory loss, tinnitis, altered sleep patterns, digestive disturbances,
and tremor, termed the 'serotonin syndrome' (1). Indeed, the manufacturer (Wyeth)
could face charges for failure to issue proper warnings (2). New guidance from
the FDA recognises the adverse consequences of Venlafaxine discontinuation (4).
It is notable that the information issued with Venlafaxine (Efexor XL) in November
2001 only speaks of transient adverse effects 'for a few days' (5).
In summary, the prominent side-effects (6) including debilitating inertia are
clearly undesirable when comparable results can be obtained with other therapies(7).
Further, the duration of medication here (8 months) is, as far as I can establish,
longer than the maximum period of clinical trials 8): a strong argument can
be made that the drug administration should be restricted to less than 6 months,
with tapered discontinuation scheduled from inception.
Richard Lathe
Biomedical Sciences, Faculty of Medicine, University of Edinburgh, George Square,
Edinburgh EH8 9LS, UK (rlathe@ed.ac.uk)
References
1.http://www.effexorfx.freeuk.com/index.htm.
2.Guardian, Thursday September 6, 2001; Drug giant faces huge lawsuit.
http://society.guardian.co.uk/mentalhealth/story/0,8150,547606,00.html
4.Food and Drug Administration, March 2000. Safety Related Drug Labelling Changes
for Effexor and Effexor XR.
5.Information sheet, Efexor XL, November 2001 (Wyeth Laboratories, Taplow, Maidenhead,
UK). "If Efexor XL is stopped suddenly some patients may experience symptoms
..... these symptoms are generally non-serious and disappear within a few
day".
6.http://www.athealth.com/Consumer/mcabinet/EffexorXR.html#AdverseEvents
7. http://www.effexor.com/hcp/remission/data.jhtml.
8. http://www.effexor.com/hcp/overview/efficacy-depression.jhtml
All pages copyright ©Priory Lodge Education Ltd 1994-2004.